MUHC reports 'incredible decreases' in drug-resistant infections
The MUHC has cut the rates of Vancomycin-resistant Enterococci (VRE) and Methicillin-resistant Staphylococcus aureus (MRSA) by 64 per cent and 48 per cent respectively in the year since the move to its new Glen site. e, the MUHC's director of infection control explained to the Montreal Gazette and CBC how efforts to curb the spread of drug-resistant infections are paying off.
A race against time to diagnose deadly weight loss in cancer patients
About one third of cancer patients die because of cachexia - an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely with increased food intake. A study by researchers at the MUHC, published in Clinical Nutrition, aims to save patient lives by giving doctors a practical tool to easily diagnose cachexia before it becomes irreversible. Dr. Antonio Vigano, lead author of the paper and Director of the Cancer Rehabilitation Program and Cachexia Clinic of the MUHC, spoke to CJAD, Radio-Canada and La Presse about the tool.
RI-MUHC the third highest in research funding in Canada
The RI-MUHC is the third highest funded ($172.2 million) after Toronto’s University Health Network and the Hospital for Sick Children. For more details, check out Research Info Inc.’s press release.
[view:related_content=block_2]